ED
Elkins David V
Chief Financial Officer
OtherM
Insider track record
CFONot enough buy signals with a settled T+90 horizon to measure a track record yet.
Discover the detailed record of transactions filed by Elkins David V, Chief Financial Officer. Director active across 2 companies, notably Bristol Myers Squibb Co. Cumulatively, 19 disclosures have been logged. Split: 0 buy · 3 sells. Total volume traded: €6.7m. History available since 1 August 2021. The latest transaction was filed on 10 March 2025 (Levée d'options). Regulator: SEC (Form 4). All data is accessible without signup.
Declarations19 total
8,045 shares0Common Stock, $0.10 par valueSEC:0000014272-25-000060:0
3,459 shares@ US$57.8270.7% of flowCommon StockSEC:0001225208-24-010000:0
8,027 shares0Common Stock, $0.10 par valueSEC:0000014272-24-000054:0
1,788 shares@ US$47.5329.3% of flowCommon StockSEC:0001225208-24-003404:0
8,792 shares0Common Stock, $0.10 par valueSEC:0000014272-23-000193:0
8,025 shares0Common Stock, $0.10 par valueSEC:0000014272-23-000056:0
8,792 shares0Common Stock, $0.10 par valueSEC:0000014272-22-000205:0
4,498 shares@ US$81.134.9% of flowCommon Stock, $0.10 par valueSEC:0000014272-22-000205:1
30,000 shares@ US$71.3530.4% of flowCommon Stock, $0.10 par valueSEC:0000014272-22-000170:0
8,025 shares0Common Stock, $0.10 par valueSEC:0000014272-22-000075:0
24,577 shares0Common Stock, $0.10 par valueSEC:0000014272-22-000056:0
47,401 shares0Common Stock, $0.10 par valueSEC:0000014272-22-000017
47,401 shares0Common Stock, $0.10 par valueSEC:0000014272-22-000017:0
8,792 shares0Common Stock, $0.10 par valueSEC:0000014272-21-000230:0
8,792 shares0Common Stock, $0.10 par valueSEC:0000014272-21-000230
40,000 shares@ US$66.8832.3% of flowCommon Stock, $0.10 par valueSEC:0000014272-21-000202
40,000 shares@ US$66.8850.0% of flowCommon Stock, $0.10 par valueSEC:0000014272-21-000202:0
46,403 shares0Common Stock, $0.10 par valueSEC:0000014272-21-000195:0
46,403 shares0Common Stock, $0.10 par valueSEC:0000014272-21-000195
About Elkins David V
David V. Elkins is Executive Vice President and Chief Financial Officer at Bristol Myers Squibb Co. He is responsible for the company's financial management, including strategic planning and performance analysis. David plays a key role in guiding the company's financial direction and strategic decision-making.